QSS
RYTM icon

Quantitative Systematic Strategies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quantitative Systematic Strategies’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,632
Closed -$309K – 722
2017
Q4 		$309K Buy
+10,632
New +$281K 0.08% 377

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quantitative Systematic Strategies's RYTM Position: Q1 2018 in Review

Quantitative Systematic Strategies sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2018, closing a stake of 10,632 shares — an estimated $309K sold.

Quantitative Systematic Strategies first reported a position in RYTM in Q4 2017 and held it in 1 quarter. The position peaked at $309K in Q4 2017. 55 funds tracked by Wall St. Rank hold RYTM as of Q1 2018.

  • Quantitative Systematic Strategies reported no remaining Rhythm Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,632 Rhythm Pharmaceuticals shares in Q1 2018, an estimated $309K.
  • Quantitative Systematic Strategies first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Rhythm Pharmaceuticals position peaked at $309K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2018, filed 4 May 2018.